# Edaravone

NDC: 66794-259
Generic name: Edaravone
Labeler / Manufacturer: Piramal Critical Care Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20240708

FDA application: ANDA216199

## Active ingredients

- EDARAVONE: 30 mg/100mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"66794-259"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=66794-259
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=19862ae9-d6e1-70e6-e063-6394a90ae749